IC
LAB icon

IEQ Capital’s Standard BioTools LAB Stock Holding History

IEQ Capital’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
199,864
+81,314
+69% +$76.8K ﹤0.01% 1869
2026
Q1 		$109K Buy
118,550
+79,995
+207% +$96.8K ﹤0.01% 1787
2025
Q4 		$49.4K Sell
38,555
-7,989
-17% -$10.7K ﹤0.01% 1805
2025
Q3 		$60.5K Buy
46,544
+630
+1% +$825 ﹤0.01% 1788
2025
Q2 		$55.1K Sell
45,914
-17,268
-27% -$19.1K ﹤0.01% 1758
2025
Q1 		$68.2K Buy
+63,182
New +$88.7K ﹤0.01% 1528

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

IEQ Capital's LAB Position: Q2 2026 in Review

IEQ Capital increased its Standard BioTools (LAB) stake by 69% in Q2 2026, buying an estimated $76.8K and bringing the position to 199,864 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #1869.

IEQ Capital first reported a position in LAB in Q1 2025 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • IEQ Capital held 199,864 shares of Standard BioTools worth $164K as of Q2 2026.
  • IEQ Capital bought 81,314 Standard BioTools shares in Q2 2026, an estimated $76.8K.
  • Standard BioTools made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1869 holding.
  • IEQ Capital first reported a position in Standard BioTools in Q1 2025 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.